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Background: Chrysanthemum indicum L. flower (CIF) has been widely used as tea in Korea. This study aims to
investigate the hepatoprotective effect of the hot water extract of CIF (HCIF) in in vitro and in vivo systems.
Methods: Hepatoprotective activities were evaluated at 250 to 1000 μg/mL concentrations by an in vitro assay
using normal human hepatocytes (Chang cell) and hepatocellular carcinoma cells (HepG2) against CCl4-induced
cytotoxicity. Cytochrome P450 2E1, which is a key indicator of hepatic injury, was detected by western blot analysis
using rabbit polyclonal anti-human CYP2E1 antibody. An in vivo hepatoprotective activity assay was performed at
1000 to 4000 μg/mL concentrations on CCl4-induced acute toxicity in rats, and the serum levels of glutamic
oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), alkaline phosphatase (ALP) and lactate
dehydrogenase (LDH) were determined by standard enzyme assays.
Results: The hepatoprotective effects of HCIF significantly reduced the levels of GOT (60.1%, P = 0.000) and GPT
(64.5%, P = 0.000) compared with the vehicle control group (CCl4 alone). The survival rates of HepG2 and Chang
cells were significantly improved compared with the control group [82.1% (P = 0.034) and 62.3% (P = 0.002),
respectively]. HCIF [50 mg/kg body weight (BW)] treatment significantly reduced the serum levels of GOT (49.5%,
P = 0.00), GPT (55.5%, P = 0.00), ALP (30.8%, P = 0.000) and LDH (45.6%, P = 0.000) compared with the control group
in this in vivo study. The expression level of cytochrome P450 2E1 (CYP2E1) protein was also significantly decreased
at the same concentration (50 mg/kg BW; P = 0.018).
Conclusion: HCIF inhibited bioactivation of CCl4-induced hepatotoxicity and downregulates CYP2E1 expression
in vitro and in vivo.Background
The liver is the major organ for the metabolism of xeno-
biotics and drugs. CCl4 is a widely used chemical and
causes severe liver tissue damage by undergoing bio-
transformation by the cytochrome P450 system into a
trichloromethyl free radical (CCl3
•) and transformation
into a highly reactive trichloromethylperoxy free radical
(CCl3O2
•). The resulting free radical damages liver cell
membranes and organelles and causes swelling, necrosis
of hepatocytes and the release of cytosolic enzymes, such
as glutamic oxaloacetic transaminase (GOT), glutamic
pyruvic transaminase (GPT), alkaline phosphatase (ALP)
and lactate dehydrogenase (LDH), into serum and even-
tually kills cells [1-3]. Oriental traditional medicine has
used the aerial parts (stem, leaves and flowers) of* Correspondence: chsong@daegu.ac.kr
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reproduction in any medium, provided the orChrysanthemum indicum to treat hypertensive symp-
toms and several infectious diseases, such as fever and
stomatitis [4]. Notably, its flowers, which are used as
traditional tea in Korea and China [5], are widely consid-
ered to have health benefits. Therefore, we investigated
C. indicum L. flowers in this study. Chrysanthemum
indicum L. flower (CIF) is a wild herb and has a long
history of use as a traditional medicine, mainly for the
treatment of inflammation, hypertension and respiratory
diseases in Korean and Chinese medicine [6-9]. Several
studies have demonstrated that the water extract of
C. indicum L. has strong antioxidant effects and inhibitory
effects against bacteria and viruses [10,11]. In addition, the
methanol extract shows inhibitory activity of xanthine
oxidase [12]. Several chemical compounds isolated from
CIF exhibit inhibitory activity against nitric oxide (NO) in
lipopolysaccharide-activated macrophages and rat lens
aldose reductase [13].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reduced levels of reactive metabolites from xenobiotic
exposure, decreasing liver injury [2,14]. Although several
cytochrome P450 isoforms may metabolize CCl4, the
cytochrome P450 2E1 (CYP2E1) isoform, which is etha-
nol inducible [15-17], has been widely studied. Altering
expression of CYP2E1 activity affects susceptibility to
hepatic injury from CCl4 [18,19]. The expression of indi-
vidual cytochrome P450 enzymes is regulated by both
endogenous factors and foreign compounds, including
drugs and natural compounds [20]. Natural compounds
that reduce such bioactivating enzymes could be consid-
ered protective candidates against chemically induced
toxicity, and CYP2E1 is well recognized for its role in
the activation of many chemicals resulting in toxic and
carcinogenic effects.
To our knowledge, no study has been conducted to
determine the hepatoprotective effect of C. indicum L.
against CCl4-induced toxicity. This study aims to investi-




Bovine serum albumin (BSA), 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), dimethyl sulfox-
ide (DMSO), sodium bicarbonate, silymarin and CCl4 were
purchased from Sigma Chemical Co. (St. Louis, MO,
USA). Fetal bovine serum (FBS), RPMI 1640 medium,
Dulbecco’s modified Eagle’s medium (DMEM), trypsin-
ethylenediaminetetraacetic acid (EDTA), penicillin and
streptomycin were purchased from GIBCO BRL (Grand
Island, NY, USA). GOT, GPT, ALP and LDH assay kits were
purchased from Asan Pharmacology Co. (Seoul, Korea).
Rabbit polyclonal anti-human CYP2E1 antibody was pur-
chased from Chemicon International Inc. (Temecula, CA,
USA). Goat polyclonal anti-human β-actin antibody, anti-
rabbit IgG and anti-goat IgG were supplied by Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
Preparation of hot water extract of CIF (HCIF)
CIF was obtained from the Daegu traditional medicine
market (Seoul, Korea) and authenticated based on its
microscopic and macroscopic characteristics by a local bot-
any expert (Dr. Yang, Director, The Research Center for
Resource of Oriental Medicine). CIFs (100 g) were ground
into powder and decocted with distilled water (1 L) for 2 h.
The decoction was collected twice, filtered (filter paper pore
size, 0.45 μm) and lyophilized to obtain the HCIF. The
HCIF was dissolved in saline for oral administration to rats.
Cell cultures and viability
Hepatocellular carcinoma HepG2 (KCLB 88065) and nor-
mal human hepatocyte Chang (ATCC CCL-13) cell lineswere obtained from the Korean Cell Line Bank (KCLB,
Seoul, Korea) and American Type Culture Collection
(ATCC, Manassas, VA, USA), respectively. The HepG2
and Chang cells were grown in RPMI-1640 and DMEM
supplemented with 10% FBS, streptomycin (100 U/mL),
penicillin (100 μg/mL) and sodium bicarbonate (3.7 g/mL).
The cultures were maintained in 100-mm dishes at 37°C in
a 5% CO2 humidified incubator (3111, ThermoForma,
Ohio, USA). The cell viabilities of HCIF in HepG2 and
Chang cells damaged by CCl4 were measured by the MTT
assay. Briefly, cells were plated at a density of 2 × 105 cells
per well in a 96-well flat-bottom microtiter plate at three
concentrations (250, 500 and 1000 μg/mL) of HCIF. After
a 24-h incubation, the culture media were replaced with
media containing CCl4 (8 mM) and incubated for 2 h. At
the end of the incubation, 25 μL of MTT solution
(5.0 mg/mL) was added to each well and incubated for
4 h at 37°C. The cells were then lysed with DMSO (200 μL
per well), and the reduced intracellular formazan product
was quantified in a Bio-Rad enzyme-linked immunosorbent
assay microplate reader (680, Bio-Rad, Hercules, CA, USA)
at 540 nm. Cell viability was expressed as the percentage of
control absorbance at 540 nm. The data are presented as
the mean of triplicate samples ± SD. Silymarin was used as
the positive control [21,22].
Animals
Male Sprague Dawley rats were purchased from Koatech
Laboratory Animal Inc. (Seoul, Korea) and kept for 1 week
on a commercial diet under environmentally controlled
conditions (room temperature 19-25°C, relative humidity
50-60%) with free access to food and water. A controlled
12 h light/12 h dark cycle was maintained. Rats weighing
180–230 g were used in the CCl4-induced hepatotoxicity
study. Animal experiments were performed in accordance
with procedures approved by the Ethics Committee for Ani-
mal Experimentation of the Korea Food Research Institute.
Treatment of animals
Liver damage was induced in rats by a 1:1 (v:v) mixture
of CCl4 and olive oil by oral gavage as described by pre-
vious reports [23-25]. Rats were randomly grouped into
four groups of nine animals each. Group I (untreated)
rats were treated with olive oil alone (1 mL/kg BW).
Group II (control) rats were treated with CCl4:olive oil
(1 mL/kg BW). Group III (positive control) rats were
pretreated with silymarin (50 mg/kg BW), and groups IV
and V rats were pretreated with HCIF at the level of 50
or 100 mg/kg BW by oral gavage daily for 7 days before
treatment with CCl4:olive oil (1:1).
Enzymatic analysis
The cells were washed with phosphate-buffered saline
(PBS) and exposed to fresh medium containing CCl4
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HCIF or medium alone. After 6 h of CCl4 treatment,
GOT and GPT levels in the medium were measured as
described in the assay kits. After removal of the medium,
cells were washed twice with ice-cold PBS and used for
western blot analysis.
In the animal experiment, all rats were anesthetized
with ether 24 h after dosing with CCl4, and blood was
then collected via the carotid artery. Plasma samples were
collected from heparinized blood after centrifugation
(Combi-514R, Hanil, Seoul, Korea) at 1,518 × g for 10 min
at 4°C. The GOT, GPT and LDH levels were measured
according to standard methods [26], and serum ALP was
estimated by the Kind and Kings method [27].Western blot analysis of CYP2E1
After treatment with CCl4, the cells were washed twice
with cold PBS and detached with 0.02% EDTA solution.
Subsequently, the cells were treated with IPH lysis buffer
and centrifuged at 14,240 × g for 20 min at 4°C. The
cells were homogenized in buffer (pH 8.0) containing
50 mM Tris–HCl, 150 mM NaCl, 0.02% NaN3, 100 μg/mL
phenylmethylsulfonyl fluoride (PMSF), 1 mg/mL aprotinin
and 1% Triton X-100. Protein concentration was deter-
mined by the Bradford protein assay kit (Bio-Rad). Twenty
micrograms samples of total cell lysates were size fraction-
ated by SDS-PAGE and electrophoretically transferred to
nitrocellulose membranes by a Hoefer electro transfer
system (Amersham Pharmacia Biotech Inc., NJ, USA).
The membranes were incubated overnight with blocking
buffer containing 10 mM Tris–HCl, 150 mM NaCl, 0.1%
Tween 20 and nonfat dry milk at 4°C. The membranes
were then incubated for 2 h at room temperature with
1:1000 diluted primary antibodies (rabbit polyclonal anti-
human CYP2E1 antibody and goat polyclonal anti-
human β-actin antibody). After washing with blocking
buffer 3 times for 10 min, membranes were probed
with 1:2000 diluted secondary antibodies (horseradish
peroxidase-linked anti-rabbit, anti-goat IgG) for 1 h,
washed 3 times for 10 min and developed with an ECL
western blotting detection system (Amersham Pharmacia
Biotech Inc.).Histopathological examination
Fresh liver tissues, previously trimmed to approximately
2-mm thickness, were placed in plastic cassettes and
immersed in neutral buffered formalin for 24 h. Fixed
tissues were processed routinely and then embedded
in paraffin, sectioned, deparaffinized and rehydrated.
The extent of CCl4-induced necrosis was evaluated by
morphological changes in liver sections stained with
hematoxylin and eosin (Axiolab reflected light micro-
scope, Carl Zeiss, Germany).Statistical analysis
The results are presented as the mean ± SD (calculated
from n = 3 and n = 9 in the in vitro and in vivo studies,
respectively). The significance of differences among
groups of data was determined using SPSS 18.0 for Win-
dows (IBM, Chicago, IL, USA). Student’s t-test was used
to compare two independent groups. Statistical signifi-
cance was accepted for P values of < 0.05.
Results
Effect of HCIF on CCl4-induced hepatotoxicity in vitro
The 8 mM CCl4-exposed HepG2 and Chang cells
exhibited cell viabilities of 58% and 39%, respectively,
compared with untreated controls (Figure 1). Viability of
these CCl4-exposed cells was exhibited in a dose-
dependent manner when pretreated with various HCIF
concentrations. The percentage viability of HCIF + CCl4
was less than the silymarin + CCl4, which produced 82%
cell viability (P = 0.034) at a dose of 8 mM compared
with the CCl4-treated control group.
CCl4-induced hepatocyte cell lines expressed high
levels of GOT and GPT as shown in Figure 2. However,
GOT (39.8 IU/L) and GPT (44.3 IU/L) levels were
reduced in the 4 mg/mL HCIF-treated HepG2 cells
and significantly reduced by 60.1% (P = 0.000) and
64.5% (P = 0.000), respectively, compared with the con-
trol group. Likewise, HCIF effectively and significantly
lowered levels of GPT (33.4 IU/L; P = 0.000) and GOT
(34.2 IU/L; P = 0.002) in Chang cells. Silymarin also
caused a significant reduction in GOT and GPT leakage
(P = 0.000) at 4 mg/mL HCIF.
Effect of HCIF on CCl4-induced hepatotoxicity in vivo
CCl4 treatment caused a significant elevation of serum
GOT, GPT, ALP and LDH activities (5-, 10-, 2- and 3.5-
fold, respectively) in rats. These elevated activities were
significantly decreased by 50 mg/kg BW HCIF treatment
[49.5% (P = 0.000), 55.5% (P = 0.000), 30.8% (P = 0.000) and
45.6% (P = 0.000), respectively]. Silymarin also significantly
reduced the CCl4-induced elevation of serum enzymatic
activities at 50 mg/kg BW concentration (P = 0.000).
In the CCl4-induced acute hepatitis model (Table 1),
inhibitory effects of HCIF on the release of GOT and GPT
into rat serum were similar to or lower than the corre-
sponding effects mediated by silymarin (50 mg/kg BW).
The reduction of GOT, GPT, ALP and LDH levels after
administration of HCIF could indicate the stabilization of
the plasma membrane in liver and repair of hepatic tissue
damage caused by CCl4.
Effect of HCIF on CYP2E1 expression
Silymarin decreased CYP2E1 protein levels in vitro and
in vivo (Figures 3 and 4, lane 3). CYP2E1 expression in
Chang cells was suppressed by HCIF treatment in a
Figure 1 Protective effect of the Chrysanthemum indicum L. flower hot water extract (HCIF) against CCl4-induced cytotoxicity in a
hepatocyte cell line. Untreated, cells alone; Control, cells + CCl4; S, cell + CCl4 + silymarin; HCIF, cell + CCl4 + HCIF.
*P < 0.05, **P < 0.01 and
***P < 0.001, significantly different from the control group.
Figure 2 Effect of HCIF on GOT and GPT leakage in a hepatocyte cell line. Untreated, cells alone; Control, cells + CCl4; S, cell + CCl4 +
silymarin (1 mg/mL); HCIF, exposed to cell + CCl4 + CIF (1, 2 and 4 mg/mL).
*P < 0.05, **P < 0.01 and ***P < 0.001, significantly different from
the control group. #P < 0.001, significantly different from the untreated group.
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Table 1 Hepatoprotective effect of HCIF on CCl4-induced toxicity in rats
GOT (IU/L) GPT (IU/L) ALP (IU/L) LDH (IU/L)
Untreated 41.4 ± 5.9 14.2 ± 0.4 161.6 ± 16.7 720.4 ± 51.1
CCl4-treated control 197.3 ± 10.4
# 148.6 ± 9.6# 330.5 ± 36.3# 2516.2 ± 439.4#
Silymarin + CCl4 (50 mg/kg) 71.5 ± 4.9
*** 60.5 ± 6.8*** 202.3 ± 34.2*** 1122.1 ± 135.5***
HCIF50 + CCl4 (50 mg/kg) 99.5 ± 7.8
*** 66.1 ± 14.0*** 228.7 ± 26.3*** 1368.6 ± 144.3***
Serum GOT, GPT, ALP and LDH levels were determined by commercial kits. Each value is the mean ± SD; n = 9 rats. #P < 0.001, significantly different from the
untreated group. ***P < 0.01, significantly different from the CCl4-treated control group.
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levels were also reduced to 43.1% (P = 0.018) in vivo at a
dose of 50 mg/kg BW (Figure 4, lane 4).
Histopathological examination
We examined whether HCIF could affect anatomical
changes in injured liver tissue. Photomicrographs of
hematoxylin and eosin-stained liver tissue are shown in
Figure 5. Histopathological changes were prominent
compared with those in rats in the untreated (group I)
and control (group II) groups. No histological abnormal-
ities were observed of group I (Figure 5A). However, he-
patocytes around the central vein revealed complete
necrosis (arrow b) and loss of the cellular boundary
(Figure 5B) in group II. Additionally, hepatic cells were
found to have fatty degeneration (arrow c) and cytoplas-
mic vacuolization (arrow a). Numerous diffuse balloon-
ing degeneration of different sizes and larger magnitudeFigure 3 Western blot analysis of CYP2E1 levels in Chang cell
line. The expression level of CYP2E1 protein was detected by
western blot analysis with anti-human CYP2E1 antibody. Chang cells
were treated with saline (lane 1, untreated), CCl4 (lane 2, control),
CCl4 + silymarin 1 mg/mL (lane 3), CCl4 + HCIF 1 mg/mL (lane 4),
CCl4 + HCIF 2 mg/mL (lane 5) and CCl4 + HCIF 4 mg/mL (lane 6). All
bands were quantified by densitometric analysis. Each bar represents
the mean ± SD replicated in triplicate. **P < 0.01 and ***P < 0.001,
significantly different from the control group. #P < 0.001, significantly
different from the untreated group.compared with group I was observed. Pretreatment of
HCIF (Figure 5D and E) resulted in less severe histo-
pathological alterations compared with group II. Fur-
thermore, remarkable changes, such as less ballooning
degeneration, cytoplasmic vacuolization and fatty degen-
eration, were observed in the CCl4 + HCIF-treated rat
livers compared with that of group II. The numbers of
CCl4-induced histopathological alterations were dramat-
ically decreased in the HCIF-treated (group IV and V)
and 50 mg/kg silymarin treatment (group III) groups.
Discussion
Water extracts derived from many natural products possess
hepatoprotective effects [28,29]. The hepatoprotective ef-
fects of HCIF were investigated in this study. CCl4-induced
toxicity is commonly used to study the hepatoprotective ef-
fects of drugs or medicinal plant extracts using in vivo and
in vitro techniques [14,30]. Usually, the extent of hepatic
damage is assessed by histopathological examination and
measurement of GOT, GPT and ALP levels released intoFigure 4 Western blot analysis of CYP2E1 levels in rat liver. The
expression level of CYP2E1 was detected by western blot analysis of
protein samples from rat liver. Rats were treated with olive oil (lane 1,
untreated), CCl4 + saline (lane 2, control), CCl4 + silymarin 50 mg/kg BW
(lane 3, silymarin) and CCl4 + CIF 50 mg/kg BW (lane 4, HCIF) for 7 days.
All hepatotoxicity was induced in rats with 1 mg/kg body weight of
CCl4. All bands were quantified by densitometric analysis.
*P < 0.05 and
**P < 0.01, significantly different from the control group. #P < 0.01,
significantly different from the untreated group.
Figure 5 Photomicrographs of paraffin-embedded rat liver. Each sample was pretreated for 7 days and then treated with a single dose of
CCl4. (A) untreated group (group I); (B) CCl4 alone (group II); (C) silymarin (50 mg/kg BW, group III); (D) HCIF (50 mg/kg BW, group IV); (E) HCIF
(100 mg/kg BW, group V); (F) tea seed oil (200 mg/kg BW, group VI). All hepatotoxicity was induced in rats with 1 mg/kg body weight of CCl4
and analyzed 24 h later. Each of the arrows indicated vacuole formation (a), necrosis (b) and fatty degeneration (c).
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cantly affected CCl4-induced hepatotoxicity in hepatocyte
cell lines and rats. Recovery of normal serum levels of
transaminases indicated healing of hepatic parenchyma and
regeneration of hepatocytes [33]. In this study, enzyme
levels significantly decreased to 49.5% and 55.5% at 50 mg/
kg BW dose of HCIF, suggesting that HCIF has a potent
hepatoprotective effect on CCl4-treated rats. GOT and
GPT levels in hepatocytes in this cell culture study were
comparable to in vivo results.
The hepatocellular carcinoma cell line HepG2 is a reli-
able model that is easy to culture, well characterized and
widely used for biochemical and drug toxicity studies.
HepG2 cells possess many morphological and biochemical
features of normal hepatocytes, and many hepatoprotective
compounds have been studied using HepG2 cells [34-38].
Silymarin or its main ingredient silibinin can inhibit
cancer cells [39]. In this study, silymarin increased cellviability resulting from CCl4-induced hepatotoxicity.
The mechanism of CCl4-induced damage involves
the biotransformation of CCl4 into a highly reactive
trichloromethyl free radical (CCl3
•). Silymarin is a new
hepatoprotective agent [40], which scavenges radicals,
prevents glutathione (GSH) oxidation and depletion
and stabilizes membranes [41-43]. Many previous re-
ports have confirmed that many antioxidants decrease
toxicity and lipid peroxidation induced by CCl4 [44,45].
Shear et al. [42] studied HepG2 cell viability with
silymarin, which increased HepG2 cell viability against
the oxidative metabolite of acetaminophen. In the
present study, we did not investigate whether HCIF has
anticancer effects.
Western blotting was performed on total protein sam-
ples isolated from rat liver homogenates and Chang cells
to assess CYP2E1 protein expression. CYP2E1 has been
demonstrated to be largely responsible for the activation
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rats with CYP2E1 inhibitors can protect against CCl4-in-
duced hepatotoxicity [47]. We found decreased expres-
sion of CYP2E1 protein in HCIF-treated Chang cells
(Figure 3) and hepatic microsomes in HCIF-treated
rats (Figure 4). The phytochemical profile of HCIF con-
tains large amounts of caffeic acid, luteolin, kaempferol,
flavonoids, terpenoids and phenolic compounds [13,48].
Polyphenols, which are strong antioxidants, prevent
ethanol-induced CYP2E1 expression in HepG2 cells
[49]. The downregulation of CYP2E1 expression de-
creases the formation of CCl3
• and reduces hepatocyte
necrosis and hepatocellular injury [47]. Several previous
studies have demonstrated that CCl4-induced hepatotox-
icity could be modulated by substances that influence
CYP2E1 activity [50,51]. In particular, compounds or
drugs that induce CYP2E1 could potentiate the hepatic
toxicity of CCl4 [52,53]. Compounds that inhibit CYP2E1
could protect cells against CCl4-induced toxicity [22,46].
The induction or inhibition of CCl4 biotransformation
may subsequently influence metabolic activation or de-
toxification of CCl4. Generally, CYP2E1 participates in the
metabolism of small organic molecules, such as carbon
tetrachloride, acetaminophen and nitrosamines [15,17,54].
Thus, CYP2E1 inhibition by HCIF not only protects cells
against CCl4-induced hepatotoxicity, but also reduces
xenobiotic toxicity.
CCl4 causes increased formation of pro-oxidants
(trichloromethyl radical) and a concomitant decrease
in the antioxidant status of the cell [55]. Overproduction
of oxygen radicals causes an imbalance in oxidant-
antioxidant capacity and increased attacks on unsaturated
fatty acid of lipid structures leading to lipid peroxidation
and damaging effects on proteins [56]. These pro-oxidant
molecules attack microsomal lipids and form peroxidation
products [57,58]. Changes in biochemical indices and
histopathological appearance in CCl4-treated rats were
significant when compared with the untreated group
(group I). HCIF-pretreated rats showed a significant
hepatoprotective effect of HCIF against CCl4-induced liver
injury in rats. The histopathological appearance and bio-
chemical indices of 50 mg/kg BW HCIF-pretreated rats
were similar to that of the untreated group (group I). CCl4
treatment of rats markedly increased serum ALP and
LDH levels, which reflect the severity of liver injury [59].
Large quantities of ALT and LDH secreted into serum
may be associated with severe liver injury. As previously
reported, CIF has a large amount of phenolic compounds,
and the water extract of CIF exhibited high antioxidant
activity [60]. Lipid peroxidation, the principal cause of
CCl4-induced liver injury, is associated with the free-
radical metabolite of CCl4. One of the hepatoprotective
activities of HCIF may also result from its antioxidative
properties.Conclusions
HCIF inhibited bioactivation of CCl4-induced hepatotox-
icity and downregulated CYP2E1 expression in vitro and
in vivo.
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